Concourse Financial Group Securities, Inc. Sellas Life Sciences Group, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
38Shares Held
7.08MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.96 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.54 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$946,2740.0% of portfolio
-
Brooklyn Fi, LLC New York, NY595KShares$767,4450.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$626,0580.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $26.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...